Bispecific Soluble Cytokine Receptor-Nanobody Fusions Inhibit Interleukin (IL-)6 Trans-Signaling and IL-12/23 or Tumor Necrosis Factor (TNF) Signaling.
Journal of biological chemistry/The Journal of biological chemistry(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要